Authors:
Payen, L
Courtois, A
Langouet, S
Guillouzo, A
Fardel, O
Citation: L. Payen et al., Unaltered expression of multidrug resistance transporters in polycyclic aromatic hydrocarbon-resistant rat liver cells, TOXICOLOGY, 156(2-3), 2001, pp. 109-117
Authors:
Laupeze, B
Amiot, L
Payen, L
Drenou, B
Grosset, JM
Lehne, G
Fauchet, R
Fardel, O
Citation: B. Laupeze et al., Multidrug resistance protein (MRP) activity in normal mature leukocytes and CD34-positive hematopoietic cells from peripheral blood, LIFE SCI, 68(11), 2001, pp. 1323-1331
Authors:
Payen, L
Delugin, L
Courtois, A
Trinquart, Y
Guillouzo, A
Fardel, O
Citation: L. Payen et al., The sulphonylurea glibenclamide inhibits multidrug resistance protein (MRP1) activity in human lung cancer cells, BR J PHARM, 132(3), 2001, pp. 778-784
Authors:
Vernhet, L
Allain, N
Payen, L
Anger, JP
Guillouzo, A
Fardel, O
Citation: L. Vernhet et al., Resistance of human multidrug resistance-associated protein 1-overexpressing lung tumor cells to the anticancer drug arsenic trioxide, BIOCH PHARM, 61(11), 2001, pp. 1387-1391
Authors:
Payen, L
Courtois, A
Loewert, M
Guillouzo, A
Fardel, O
Citation: L. Payen et al., Reactive oxygen species-related induction of multidrug resistance-associated protein 2 expression in primary hepatocytes exposed to sulforaphane, BIOC BIOP R, 282(1), 2001, pp. 257-263
Authors:
Payen, L
Courtois, A
Campion, JP
Guillouzo, A
Fardel, O
Citation: L. Payen et al., Characterization and inhibition by a wide range of xenobiotics of organic anion excretion by primary human hepatocytes, BIOCH PHARM, 60(12), 2000, pp. 1967-1975
Authors:
Courtois, A
Payen, L
Vernhet, L
de Vries, EGE
Guillouzo, A
Fardel, O
Citation: A. Courtois et al., Inhibition of multidrug resistance-associated protein (MRP) activity by rifampicin in human multidrug-resistant lung tumor cells, CANCER LETT, 139(1), 1999, pp. 97-104
Authors:
Courtois, A
Payen, L
Vernhet, L
Morel, F
Guillouzo, A
Fardel, O
Citation: A. Courtois et al., Differential regulation of canalicular multispecific organic anion transporter (cMOAT) expression by the chemopreventive agent oltipraz in primary rat hepatocytes and in rat liver, CARCINOGENE, 20(12), 1999, pp. 2327-2330
Authors:
Courtois, A
Payen, L
Lagadic, D
Guillouzo, A
Fardel, O
Citation: A. Courtois et al., Evidence for a multidrug resistance-associated protein 1 (MRP1)-related transport system in cultured rat liver biliary epithelial cells, LIFE SCI, 64(9), 1999, pp. 763-774
Authors:
Payen, L
Courtois, A
Vernhet, L
Guillouzo, A
Fardel, O
Citation: L. Payen et al., The multidrug resistance-associated protein (MRP) is over-expressed and functional in rat hepatoma cells, INT J CANC, 81(3), 1999, pp. 479-485
Authors:
Courtois, A
Payen, L
Guillouzo, A
Fardel, O
Citation: A. Courtois et al., Up-regulation of multidrug resistance-associated protein 2 (MRP2) expression in rat hepatocytes by dexamethasone, FEBS LETTER, 459(3), 1999, pp. 381-385
Authors:
Vernhet, L
Courtois, A
Allain, N
Payen, L
Anger, JP
Guillouzo, A
Fardel, O
Citation: L. Vernhet et al., Overexpression of the multidrug resistance-associated protein (MRP1) in human heavy metal-selected tumor cells, FEBS LETTER, 443(3), 1999, pp. 321-325
Authors:
Payen, L
Delugin, L
Courtois, A
Trinquart, Y
Guillouzo, A
Fardel, O
Citation: L. Payen et al., Reversal of MRP-mediated multidrug resistance in human lung cancer cells by the antiprogestatin drug RU486, BIOC BIOP R, 258(3), 1999, pp. 513-518